Search

everythinglearnresearchcommunity

for

Search:↓

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

People with alopecia areata had lower vitamin D levels, but these levels didn't relate to many aspects of the condition.

Immunotherapy can help treat severe alopecia areata.

Trichoscopy is essential for diagnosing and managing alopecia areata in children.

The Lexington LaserComb helped regrow hair in mice with a condition similar to human hair loss.

COVID-19 infection may trigger alopecia areata in some patients.

Platelet-rich plasma (PRP) is a safe and potentially effective way to treat hair loss, especially when combined with minoxidil.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Superficial cryotherapy is effective and safe for treating alopecia areata, with better results when used early and frequently.

Clobetasol and pimecrolimus are similarly effective for alopecia areata, but pimecrolimus has fewer side effects and is preferred for long-term use.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

A hand-held dermatoscope helped differentiate between pressure-induced alopecia and alopecia areata in a young patient, who then experienced hair regrowth within a month.

Hair transplant surgery effectively treated a specific type of hair loss and is recommended as a primary treatment option.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Platelet rich plasma is an effective treatment for alopecia areata.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

A 3-year-old girl with skin mast cell buildup and congenital baldness improved with treatment, suggesting a rare link between these conditions.

IL-1α levels are higher in alopecia areata patients, suggesting a role in the disease.

Upadacitinib may effectively treat alopecia areata without side effects.

Adding PRP to topical mometasone improves and speeds up alopecia areata treatment.

People with alopecia areata have much lower Vitamin-D levels than healthy individuals.

Both Betasalic ointment and 5% minoxidil are effective and safe for treating Alopecia Areata.

Combination therapy with cyclosporine and low-dose corticosteroid shows favorable long-term results for treating alopecia areata.

Niosomal minoxidil, when applied topically, increases hair count more than conventional minoxidil solution.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Alopecia areata treatment varies, with no optimal method established yet.

FFA's causes may include environmental triggers and genetic factors.